Sarepta Therapeutics Inc (SRPT)

119.98 -1.40 (-1.15%)
Closed USD Disclaimer
120.25 +0.27 (+0.23%)

SRPT Balance Sheet

Total Current Assets
Name
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
2,464.86 2,579.33 2,450.85 2,472.61 2,488.38
Cash and Short Term Investments 1,390.74 1,676.25 1,733.54 1,860.72 1,882.10
Cash - - - - -
Cash & Equivalents 427.29 428.43 541.93 851.93 871.67
Short Term Investments 963.45 1,247.82 1,191.61 1,008.79 1,010.43
Total Receivables, Net 419.38 439.71 354.26 267.16 288.08
Accounts Receivables - Trade, Net 408.90 430.11 354.26 265.44 285.87
Total Inventory 373.53 322.86 244.01 226.88 202.68
Prepaid Expenses 34.31 30.15 28.24 27.40 28.73
Other Current Assets, Total 246.90 110.36 90.79 90.47 86.80
3,224.38 3,264.58 3,109.71 3,125.89 3,059.79
Property/Plant/Equipment, Total - Net 375.57 357.11 345.82 323.60 244.88
Property/Plant/Equipment, Total - Gross 548.08 - - - -
Accumulated Depreciation, Total -190.97 - - - -
Goodwill, Net - - - - -
Intangibles, Net 28.93 29.62 19.50 18.02 7.20
Long Term Investments 7.46 6.53 7.50 31 31
Note Receivable - Long Term 10.48 9.59 1.72 2.20 -
Other Long Term Assets, Total 347.56 291.99 286.04 280.66 288.33
Other Assets, Total 1,164.50 1,241.34 1,172.15 1,058.97 1,011.83
608.71 653.66 450.74 498.65 536.88
Accounts Payable 91.54 164.92 87.95 109.80 106.71
Payable/Accrued - - - - -
Accrued Expenses 154.22 200.08 202.61 219.61 253.32
Notes Payable/Short Term Debt - - - - -
Current Port. of LT Debt/Capital Leases 121.86 123.33 17.95 16.99 17.38
Other Current liabilities, Total 241.10 165.33 142.23 152.26 159.47
2,263.19 2,405.24 2,345.35 2,384.48 2,347.04
Total Long Term Debt 1,133.66 1,132.52 1,236.76 1,235.52 1,234.28
Long Term Debt 1,133.66 1,132.52 1,236.76 1,235.52 1,234.28
Capital Lease Obligations - - - - -
Deferred Income Tax - - - - -
Minority Interest - - - - -
Other Liabilities, Total 520.82 619.06 657.85 650.31 575.87
961.19 859.34 764.36 741.41 712.75
Redeemable Preferred Stock, Total - - - - -
Preferred Stock - Non Redeemable, Net - - - - -
Common Stock, Total 0.01 0.01 0.01 0.01 0.01
Additional Paid-In Capital 5,371.97 5,304.62 5,256.85 5,193.39 5,140.15
Retained Earnings (Accumulated Deficit) -4,410.09 -4,446.21 -4,491.87 -4,450.93 -4,426.99
Treasury Stock - Common - - - - -
ESOP Debt Guarantee - - - - -
Unrealized Gain (Loss) - - - - -
Other Equity, Total -0.69 0.92 -0.64 -1.06 -0.42
3,224.38 3,264.58 3,109.71 3,125.89 3,059.79
94.49 93.73 93.54 93.27 93.14
- - - - -

* In Millions of USD (except for per share items)

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.